Cyberknife Stereotactic Body Radiation Therapy for Nonresectable Tumors of the Liver: Preliminary Results

Table 2

Tumor response, recurrence of malignancy, and adverse events in patients treated with Stereotactic Body Radiation Therapy for nonresectable liver tumors.

	HCC	IHC	LM	Total
Subjects	6	3	8	17
Mean of Follow Up (months)	10.0	5.9	6.9	7.8
Tumor Response
RECIST	Complete (0)	Complete (0)	Complete (0)	Complete (0)
	Partial (5)	Partial (2)	Partial (7)	Partial (4)
	Stable (1)	Stable (0)	Stable (1)	Stable (2)
	Progress (0)	Progress (1)	Progress (0)	Progress (1)
Partial Tumor	Grade I (0)	Grade I (2)	Grade I (0)	Grade I (2)
Response Grade	Grade II (3)	Grade II (0)	Grade II (2)	Grade II (5)
	Grade III (3)	Grade III (1)	Grade III (6)	Grade III (10)
Tumor Recurrence
	Grade 0 (4)	Grade 0 (1)	Grade 0 (4)	Grade 0 (9)
	Grade 1a (0)	Grade 1a (0)	Grade 1a (0)	Grade 1a (0)
	Grade 1b (0)	Grade 1b (1)	Grade 1b (0)	Grade 1b (1)
	Grade 2 (1)	Grade 2 (1)	Grade 2 (2)	Grade 2 (4)
	Grade 3 (1)	Grade 3 (0)	Grade 3 (0)	Grade 3 (1)
	Grade 4 (0)	Grade 4 (0)	Grade 4 (2)	Grade 4 (2)
Adverse events
From SBRT	0	0	0	0
From markers	0	0	2	2
From surgery	0	0	0	0
# Patients Expired	2	3	3	8